Full-Time
Global medical devices for orthopedics
€49k - €73.3k/yr
Sant Cugat del Vallès, Barcelona, Spain
Hybrid
Hybrid role; occasional on-site days may be required in Spain or Poland.
See people who can refer or advise you
Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.
Company Size
10,001+
Company Stage
IPO
Headquarters
Watford, United Kingdom
Founded
1856
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Holidays
Flexible Work Hours
Parental Leave
Fertility Treatment Support
Family Planning Benefits
Tuition Reimbursement
Wellness Program
Mental Health Support
Volunteer Time Off
Home Office Stipend
Phone/Internet Stipend
Discounted Stock Options
Health Savings Account/Flexible Spending Account
Employee Assistance Program
PTO/vacation?
Paid Sick Leave
Smith+Nephew has launched ASC Solutions, an enterprise strategy designed to help ambulatory surgery centres optimise costs, improve quality and enhance performance. The initiative provides ASCs with access to clinical expertise, procedural technologies and data analytics to support growth and patient outcomes in value-based care settings. The company is expanding its ASC ONE delivery model into an integrated platform that simplifies centre development and accelerates facility readiness. ASC ONE coordinates services including facility design, construction, financing and clinical enablement through a single point of contact. Smith+Nephew has partnered with STERIS Unity Health Centers, Brasfield & Gorrie, Ghafari and Hopper Healthcare to provide expertise across the ASC lifecycle. The model enables physician-led organisations and health systems to streamline vendor management whilst reducing complexity and improving execution timelines.
Smith+Nephew has completed the first clinical cases using its next-generation CORI XT Handheld Robotics Platform for knee and shoulder arthroplasty. The platform is designed as a single handheld robotics system for various orthopaedic procedures, including partial to revision knee, hip, and anatomic and reverse shoulder surgeries. The first shoulder arthroplasty cases were performed at Duke Health by Dr Christopher Klifto, who used CORI SHOULDER Handheld Robotic Arthroplasty with the AETOS Shoulder System. Dr Bertrand Kaper subsequently completed the first CORI XT shoulder cases in an ambulatory surgery centre setting in Scottsdale, Arizona. The platform supports both hospital and ambulatory surgical centre environments, with a compact footprint tailored to different facility needs. Smith+Nephew's approach aims to enhance surgeon expertise whilst maintaining clinical control and workflow efficiency.
Smith+Nephew has launched the next generation LEAF Patient Monitoring System in the US, a pressure injury prevention platform designed to reduce hospital-acquired pressure injuries (HAPIs). The cloud-hosted system uses wearable sensors to monitor patient mobility and provide real-time turn status updates, improving workflow efficiency and protocol adherence. HAPIs cause approximately 60,000 annual deaths in the US and cost the economy $26.8 billion yearly. The LEAF system has demonstrated a 73% reduction in HAPI odds compared to standard care and delivers up to $1.8 million in estimated savings per critical care facility. The enhanced platform features an improved user interface developed with nursing teams and integrates seamlessly with hospital electronic medical records. It currently monitors over 150,000 patients annually across healthcare facilities.
Bernstein has cut its price target on Smith & Nephew to $31.85 from $36.20, maintaining a Market Perform rating. The adjustment followed the medical device company's fiscal Q1 trading update, which showed organic sales growth of 3.1%, missing the consensus estimate of 3.8%. Canaccord also reduced its price target to $30 from $32 the same day, keeping a Hold rating. Smith & Nephew reported Q1 revenue of $1.5 billion, with underlying revenue growth of 3.1% and reported growth of 6.6%, including a 350 basis point foreign exchange tailwind. The company develops and sells medical devices across three segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management.
Smith+Nephew is launching two chronic wound care products at the European Wound Management Association Conference in Bremen from 6–8 May 2026. The innovations address a challenge affecting up to 14.9 million people in Europe and consuming up to 4% of healthcare spending. ALLEVYN COMPLETE CARE Foam Dressing features a five-layer construction with Enhanced ExuLOCK Technology that locks in exudate and bacteria, releasing up to 100 times fewer bacteria than other foam dressings. The product includes an ExuMASK Change Indicator for longer wear times and ShearDEFENSE technology to protect against pressure injuries. RENASYS EDGE Negative Pressure Wound Therapy System offers a lightweight, portable pump with modular design that eliminates annual servicing requirements. The system achieved 88% patient compliance and improved wound outcomes.